Long persistence of tumour necrosis factor‐α antagonist‐induced autoantibodies under subsequent treatment with ustekinumab but no adverse effects: a case study of 14 patients with psoriasis

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2133|178|1|e9-e10

ISSN： 0007-0963

Source： BRITISH JOURNAL OF DERMATOLOGY, Vol.178, Iss.1, 2018-01, pp. : e9-e10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effect of long‐term treatment with tumour necrosis factor‐α inhibitors on single‐dose ultraviolet‐induced changes in human skin

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : 1762-1764

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumour necrosis factor antagonist‐induced lupus: a Critically Appraised Topic

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : 1519-1526

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mechanisms of Tumor Necrosis Factor α Antagonist–Induced Lupus in a Murine Model

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 1, 2015-01 ,pp. : 225-237

John Wiley & Sons Inc

Access to resources Recommend Favorite

Specificity of human anti‐variable heavy (VH) chain autoantibodies and impact on the design and clinical testing of a VH domain antibody antagonist of tumour necrosis factor‐α receptor 1

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 182, Iss. 2, 2015-11 ,pp. : 139-148

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy comparison of ustekinumab between anti‐tumor necrosis factor‐α drug‐naïve and anti‐tumor necrosis factor‐α drug‐resistant Japanese psoriasis cases

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 11-9059, Iss. 10, 2015-10 ,pp. : 1194-1198

John Wiley & Sons Inc

Access to resources Recommend Favorite